Vigil Neuroscience, Inc. - Common Stock (VIGL)

Q3 2024 13F Holders as of 9/30/2024

Type / Class
Equity / Common Stock
Shares outstanding
46.6M
Number of holders
51
Total 13F shares, excl. options
27.7M
Shares change
-423K
Total reported value, excl. options
$94.2M
Value change
-$2.96M
Number of buys
20
Number of sells
-33
Price
$3.40

Significant Holders of Vigil Neuroscience, Inc. - Common Stock (VIGL) as of Q3 2024

66 filings reported holding VIGL - Vigil Neuroscience, Inc. - Common Stock as of Q3 2024.
Vigil Neuroscience, Inc. - Common Stock (VIGL) has 51 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 27.7M shares of 46.6M outstanding shares and own 59.44% of the company stock.
Largest 10 shareholders include Atlas Venture Life Science Advisors, LLC (5.84M shares), Northpond Ventures, LLC (4.21M shares), Siren, L.L.C. (1.99M shares), BVF INC/IL (1.81M shares), SPHERA FUNDS MANAGEMENT LTD. (1.65M shares), Point72 Asset Management, L.P. (1.6M shares), Deep Track Capital, LP (1.55M shares), CITADEL ADVISORS LLC (1.44M shares), 683 Capital Management, LLC (1.22M shares), and VANGUARD GROUP INC (905K shares).
This table shows the top 51 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.